Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. - Wikidata - awgldk - TriplyDB

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.

http://www.wikidata.org/entity/Q33468660

about

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia Altered expression of miR-181a and miR-146a does not change the expression of surface NCRs in human NK cells.hrHPV E5 oncoprotein: immune evasion and related immunotherapies.HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells Increase of IFN-γ and TNF-α production in CD107a + NK-92 cells co-cultured with cervical cancer cell lines pre-treated with the HO-1 inhibitor.NK cells and virus-related cancers.Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach.Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells.An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients.HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.Human papillomavirus immunization is associated with increased expression of different innate immune regulatory receptors Prevalence of the NKG2D Thr72Ala polymorphism in patients with cervical carcinoma.Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity Stress Management, Depression and Immune Status in Lower Income Racial/Ethnic Minority Women Co-infected with HIV and HPV.Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells.IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients.Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.HPV infection: immunological aspects and their utility in future therapy Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients.Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer.A functional polymorphism in the NKG2D gene modulates NK-cell cytotoxicity and is associated with susceptibility to Human Papilloma Virus-related cancers.High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status Optimizing therapeutic antibody function: progress with Fc domain engineering.Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands.The tumor microenvironment: a pitch for multiple players.Natural killer cell receptors: alterations and therapeutic targeting in malignancies.Cryopreserved NK cells in the treatment of haematological malignancies: preclinical study.Mutations in a Highly Conserved Motif of nsp1β Protein Attenuate the Innate Immune Suppression Function of Porcine Reproductive and Respiratory Syndrome Virus.Third-stage Gnathostoma spinigerum larva excretory secretory antigens modulate function of Fc gamma receptor I-mediated monocytes in peripheral blood mononuclear cell culture.Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.

P2860

Q26772347-30593EBC-E7C9-4252-BCA4-59B313F73623 Q26996330-33A25FDA-6B1D-4E17-BA59-4053EB39C2C6 Q27001052-B6EA1C1B-D995-4F7A-B84E-B26EB0888ACB Q27010447-E89A6E2E-60D4-4B5A-B0E6-28EC649AFCBF Q30364263-91CE65B5-76FC-42DA-8492-698DB38DDDB3 Q33730462-83DD23A1-16F1-464A-BF16-6878C3AC8AE6 Q34011491-EAFAC7F7-3F58-463F-919E-F83C0F1826F7 Q34308800-C9D8FE1A-41BB-4749-9B1A-BF2A24DE28FB Q34337237-13F71F7C-4360-4A86-98D9-43871E66FF39 Q34441128-3B33A7E1-D576-46A1-936D-C547A5222C3F Q34700290-3D98F660-EB39-441B-8F76-8A420540B733 Q34786615-2535EFDE-A653-4957-AD2A-E85C9425F06F Q34873308-EBCECEE4-8924-478D-A4C6-7AED8F6CD7B7 Q34985704-2CD384AE-98FA-4171-833F-E0AAFDCC1E13 Q35081677-D0FC4810-DAB6-427B-B251-16CF0301503B Q35541252-31BA8235-0DB9-4BB7-B1BA-02954577A5D7 Q35871517-55AD897F-E20B-4074-9588-EF183EEAD007 Q35987354-2AD3553F-5687-4488-9B3F-B084CD74BDE6 Q36086249-5328FB6A-C178-4FF9-AA15-8594B7E253C1 Q36174293-AB6B24A3-FA0C-451C-8543-50AD3ACBDF6C Q36279154-7F313EE5-FD7C-491F-BF28-7907152A6165 Q36697193-92F6F43B-DA06-4922-932C-2363C8F8C58C Q36701917-0B6983D0-D43C-48A0-9378-009D50803AC4 Q37040481-151C849E-5363-4131-9F50-3FC5D3818DA3 Q37077413-7D93D324-ED0E-4D01-8C2C-6EA3D5E50342 Q37120772-0F531A4F-E3B5-4D15-A011-5C9B7F7C6EFE Q37145093-CC08A833-BCB3-40D7-8AD8-1392EA583A61 Q37222064-D2B23D2C-1F28-4DEC-99D9-3F33C27ADEFE Q37323344-1CEC98C4-0FB0-4D9B-A3D0-A283D3C0DAF8 Q37370451-8C10AD50-463F-4690-A3EE-B8C2402267A0 Q37519488-D941EE2D-EAB9-4812-84EE-323A42DD8C99 Q37575182-629C8124-889C-4825-B68E-E4F0646AE2CE Q37804830-59ECB252-BC93-4D68-8046-33EC2B1C6176 Q38004630-7F7CCBDB-1A99-4507-8BAA-4D91C552069C Q38101567-F79BC22B-7D98-448E-B35D-561E8835EAD6 Q38587627-ED370D13-97A3-458C-930C-8A69B364A09C Q38733514-B5C0A864-42D6-41B0-91EA-27AE3366D168 Q38801171-B486767E-212B-4B9B-9A76-E44785CB6648 Q38843446-0A8F86E5-B45E-4000-B45F-282EC9283F88 Q39055067-E6E5931C-E6B4-443C-9B8C-EB5A020E32C3

P2860

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.

http://www.wikidata.org/entity/Q33468660

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Low NKp30, NKp46 and NKG2D exp ...... cancer and precursor lesions.

@ast

Low NKp30, NKp46 and NKG2D exp ...... cancer and precursor lesions.

@en

type

label

Low NKp30, NKp46 and NKG2D exp ...... cancer and precursor lesions.

@ast

Low NKp30, NKp46 and NKG2D exp ...... cancer and precursor lesions.

@en

prefLabel

Low NKp30, NKp46 and NKG2D exp ...... cancer and precursor lesions.

@ast

Low NKp30, NKp46 and NKG2D exp ...... cancer and precursor lesions.

@en

P1433

Q33468660-205B176F-72C8-4AFD-872C-BA94FFCFD93C

P1476

Q33468660-BA5C883F-2D5A-4EB1-90B9-CFE00A97B00D

P2093

Q33468660-3ECCAA68-A091-44EC-8C32-2C5788A062D2

Q33468660-4CDCDB5B-406B-4E19-AFC0-FD5E7E45A026

Q33468660-66D79F21-A3A4-40DC-8C4C-A1003D7C426E

Q33468660-8E2B181A-C079-4C63-BB80-3DB3A85DC375

Q33468660-CF74F7A8-75BA-4767-B4BD-0D0538C54259

P2860

Q33468660-003D4C4D-DC62-4183-B61C-00A6B8430526

Q33468660-0058D0E7-E69B-4486-BDA2-4B959F88D64D

Q33468660-06F68115-5968-40C0-87C1-F55315070BA6

Q33468660-1145B860-DDA2-4D90-8688-B3915D8B3D5D

Q33468660-121E506F-2031-4E39-B28A-6B05F6D12010

Q33468660-172AD125-E4BC-4813-BAD5-AAC25A2435FC

Q33468660-20AFE5B5-F5F8-4008-8CCC-B5C91C70E56C

Q33468660-2BB67C07-444C-4232-8CE1-A760D00705C0

Q33468660-2F1D6CCA-0207-4556-9115-2186443860D9

Q33468660-32BD12B5-209D-4A5D-BFBE-5FF0A37292C3

P2888

Q33468660-E0FE5C66-14EF-403A-8097-F5ABC47F23EF

P304

Q33468660-94C23500-7751-4C77-B92E-A36083E98EDC

P31

Q33468660-50CAA647-D994-4134-83BB-E478CB752599

P356

Q33468660-E15D33B2-CBB8-452D-9798-BB78D0EE4B50

P407

Q33468660-A4A4CAFC-F21C-4135-8ED1-54AB61C01D00

P478

Q33468660-D1BB6222-F09D-4AD2-92EB-F48786BEEEBB

P50

Q33468660-4B4F41A7-0D8E-4820-993C-2E3269DBA0CC

Q33468660-6CA8145A-51DA-4371-AB33-DCC9BD55B65D

Q33468660-7923F6C6-75A2-44ED-8C97-FEF4FD548307

Q33468660-94275210-CA90-4864-BF55-AB6787F0194E

Q33468660-A18074FA-19E3-4B00-BB04-D8B95A88E5EE

Q33468660-B412A54C-2F77-4DDE-989B-A82C47DDE89A

P577

Q33468660-B294A32D-2EFD-45B5-909D-3705F32E0E8B

P5875

Q33468660-2A0A2BCF-A8E7-442E-BA56-FF020578E227

P6179

Q33468660-E7C4F9B7-99B4-4231-B2CA-CE1E627E8F18

P698

Q33468660-F5844F8B-98E2-4C91-8DE3-47056741A12C

P921

Q33468660-31D47B59-16B6-42AF-8055-ABF1F470C5FD

P932

Q33468660-9D1E6C59-9E7B-422B-B83A-BF6619F3105E

P356

1471-2407-9-186

P1433

P1476

Low NKp30, NKp46 and NKG2D exp ...... l cancer and precursor lesions

@en

P2093

Alicia Del Toro-Arreola

http://www.w3.org/2001/XMLSchema#string

Benibelks Albarran-Somoza

http://www.w3.org/2001/XMLSchema#string

Maria Guadalupe Ramirez-Dueñas

http://www.w3.org/2001/XMLSchema#string

Susana Del Toro-Arreola

http://www.w3.org/2001/XMLSchema#string

Trinidad Garcia-Iglesias

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular profiling of cervical cancer progression

Correlating immunity with protection for HPV infection.

Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.

Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.

Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.

HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.

Innate and adaptive immunity in female genital tract: cellular responses and interactions.

Surface NK receptors and their ligands on tumor cells.

P2888

1471-2407-9-186

P304

186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-9-186

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Adrian Daneri-Navarro

Alejandro Bravo-Cuellar

P C Ortiz-Lazareno

Pedro Ernesto Sánchez-Hernández

P E Sánchez-Hernández

Luz Ma Adriana Balderas-Peña

P577

2009-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26296424

http://www.w3.org/2001/XMLSchema#string

P6179

1006727578

http://www.w3.org/2001/XMLSchema#string

P698

19531227

http://www.w3.org/2001/XMLSchema#string

P921

P932

2704222

http://www.w3.org/2001/XMLSchema#string